Wednesday, October 22, 2008 10:42:49 AM
Good. But that's not my primary purpose; my primary purpose is buying value. Everyone is so scared of a reverse split? Please... These people should never buy an R&D stock again, in their lifetimes. Leave it to the pros, I say. These things take understanding and patience, and R&D companies need funding. DNAPrint Genomics does already have some products on the market, it's worth noting, and a lot of very significant intellectual property. A lot of value has been built up in DNAG. The company has used their money wisely, which is exactly what an R&D company is supposed to do. I'm proud of them. I don't spread my money around indiscriminately.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM